Evidence map›Paper›PMID 32505072›Full record

ArticleMedical hypotheses2020

COVID-19 and picotechnology: Potential opportunities.

Navid Rabiee, Mohammad Rabiee, Mojtaba Bagherzadeh, Nima Rezaei

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Medical hypotheses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Article
  7. Article
  8. Quantum dots against SARS-CoV-2: diagnostic and therapeutic potentials.Journal of chemical technology and biotechnology (Oxford, Oxfordshire : 1986) · 2022
    Review
  9. Article
  10. Review
  11. Review
  12. COVID-19 in Patients with Cancer.Advances in experimental medicine and biology · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. COVID-19 and Its Global Economic Impact.Advances in experimental medicine and biology · 2021
    Article
  17. Article
  18. Article
  19. Interdisciplinary Approaches to COVID-19.Advances in experimental medicine and biology · 2021
    Article
  20. Nutrition and Immunity in COVID-19.Advances in experimental medicine and biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Navid RabieeDepartment of Chemistry, Sharif University of Technology, Tehran, Iran.
Mohammad RabieeBiomaterial Group, Department of Biomedical Engineering, Amirkabir University of Technology, Tehran, Iran. Electronic address: mrabiee@aut.ac.ir.
Mojtaba BagherzadehDepartment of Chemistry, Sharif University of Technology, Tehran, Iran. Electronic address: bagherzadeh@sharif.edu.
Nima RezaeiResearch Center for Immunodefiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran. Electronic address: rezaei_nima@tums.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Humanity's challenges are becoming increasingly difficult, and as these challenges become more advanced, the need for effective and intelligent action becomes more apparent. Meanwhile, the novel coronavirus disease (COVID-19) pandemic, which has plagued the world, could be considered as an opportunity to take a step toward the need for atomic engineering, compared to molecular engineering, as well as to accelerate this type of research. This approach, which can be expressed in terms of picotechnology, makes it possible to identify living cell types or in general, chemical and biological surfaces using their atomic arrays, and applied for early diagnosis even treatment of the disease.

Indexed as

Biomedical EngineeringCoronavirus Envelope ProteinsCoronavirus M ProteinsCOVID-19Host Microbial InteractionsHumansNanomedicineNanotechnologyPandemicsSARS-CoV-2Spike Glycoprotein, CoronavirusViral Matrix ProteinsCoronavirus Envelope ProteinsCoronavirus M Proteinsenvelope protein, SARS-CoV-2membrane protein, SARS-CoV-2Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Viral Matrix ProteinsCOVID-19NanotechnologyPicotechnologyScience

Identifiers

PMID32505072
PMCPMC7263242

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.